ImmuCell Corp. (ICCC)
9.84
-0.06
(-0.61%)
USD |
NASDAQ |
Sep 08, 16:00
9.97
+0.13
(+1.32%)
After-Hours: 20:00
ImmuCell Market Cap : 89.37M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 89.37M |
| September 04, 2026 | 89.91M |
| September 03, 2026 | 90.82M |
| September 02, 2026 | 90.82M |
| September 01, 2026 | 90.10M |
| August 31, 2026 | 88.91M |
| August 28, 2026 | 90.28M |
| August 27, 2026 | 91.00M |
| August 26, 2026 | 91.00M |
| August 25, 2026 | 89.37M |
| August 24, 2026 | 89.37M |
| August 21, 2026 | 91.37M |
| August 20, 2026 | 91.64M |
| August 19, 2026 | 92.00M |
| August 18, 2026 | 88.64M |
| August 17, 2026 | 88.10M |
| August 14, 2026 | 91.28M |
| August 13, 2026 | 99.00M |
| August 12, 2026 | 99.72M |
| August 11, 2026 | 99.45M |
| August 10, 2026 | 99.24M |
| August 07, 2026 | 99.51M |
| August 06, 2026 | 99.70M |
| August 05, 2026 | 97.25M |
| August 04, 2026 | 100.15M |
| Date | Value |
|---|---|
| August 03, 2026 | 99.88M |
| July 31, 2026 | 101.41M |
| July 30, 2026 | 100.06M |
| July 29, 2026 | 99.61M |
| July 28, 2026 | 101.69M |
| July 27, 2026 | 100.69M |
| July 24, 2026 | 99.79M |
| July 23, 2026 | 98.88M |
| July 22, 2026 | 100.69M |
| July 21, 2026 | 101.28M |
| July 20, 2026 | 100.87M |
| July 17, 2026 | 100.65M |
| July 16, 2026 | 100.69M |
| July 15, 2026 | 97.07M |
| July 14, 2026 | 106.03M |
| July 13, 2026 | 100.24M |
| July 10, 2026 | 98.52M |
| July 09, 2026 | 103.63M |
| July 08, 2026 | 96.17M |
| July 07, 2026 | 93.54M |
| July 06, 2026 | 91.01M |
| July 02, 2026 | 93.09M |
| July 01, 2026 | 99.51M |
| June 30, 2026 | 90.92M |
| June 29, 2026 | 89.65M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.747B |
| Alnylam Pharmaceuticals, Inc. | 34.78B |
| Anika Therapeutics, Inc. | 281.58M |
| Savara, Inc. | 1.136B |
| Vericel Corp. | 2.000B |
Market Cap Related Metrics
| PE Ratio | 117.42 |
| PS Ratio | 2.913 |
| Price to Book Value | 2.848 |
| Price to Free Cash Flow | 21.20 |
| Price | 9.84 |
| Earnings Yield | 0.85% |
| Operating PE Ratio | 47.88 |
| Normalized PE Ratio | 71.36 |